# PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - Nested Registry 3/Valve-in-Valve

> **NCT03225001** · NA · COMPLETED · sponsor: **Edwards Lifesciences** · enrollment: 197 (actual)

## Conditions studied

- Aortic Stenosis
- Cardiomyopathy, Hypertrophic

## Interventions

- **DEVICE:** Edwards SAPIEN XT transcatheter valve, Model 9300TFX

## Key facts

- **NCT ID:** NCT03225001
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06-11
- **Primary completion:** 2016-12-16
- **Final completion:** 2020-10-28
- **Target enrollment:** 197 (ACTUAL)
- **Last updated:** 2021-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03225001

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03225001, "PARTNER II Trial: Placement of AoRTic TraNscathetER Valves II - Nested Registry 3/Valve-in-Valve". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03225001. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*